Delivery Order SPE2DB22D3501-SPE2DB25FUU93
Award Date
3/6/25
Potential Completion Date
3/7/25
Potential Value
$1.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,793.28, is for the supply of Telmisartan-Amlodipine 40-5 mg tablets. The contract has an ultimate completion date of March 4, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Telmisartan-Amlodipine 40-5 mg tablets. The $2,774.37 Firm Fixed Price delivery order contract has an ultimate completion date of September 11, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which serves as the primary...
This federal contract award, valued at $2,648.70, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of Telmisartan-Amlodipine 40-5 mg tablets, which are used to treat cardiovascular conditions. The contract has an ultimate completion date of March 3, 2025 and is a Firm Fixed Price agreement. AmerisourceBergen holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Telmisartan-Amlodipine 40-5 mg tablets. The contract is a Delivery Order with a Firm Fixed Price pricing type and a ceiling value of $2,005.00. It has an ultimate completion date of July 31, 2024. This award is not associated with a set-aside program. AmerisourceBergen, the prime contractor, will be providing these essential...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $1,681.20, is for the delivery of Telmisartan-Amlodipine 40-10 30S, a cardiovascular medication, to support military healthcare programs. The contract has an ultimate completion date of February 12, 2025 and is a Firm Fixed Price Delivery Order. This award is part of a larger...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,949.94, is a Delivery Order for Telmisartan-Amlodipine 40-10 30s tablets, a cardiovascular medication. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
This contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $1,936.38 for the supply of Telmisartan-Amlodipine 40-5 mg medication. The contract is awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of January 21, 2025. The contract type is Firm Fixed Price. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award, valued at $56,821.15, is a Firm Fixed Price Delivery Order contract for the supply of Telmisartan-HCTZ 40-12.5 mg tablets. The contract has an ultimate completion date of November 5, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,350.18, is for the delivery of telmisartan-amlodipine 40-10 30S, a cardiovascular medication. The contract has an ultimate completion date of January 27, 2025 and is a firm fixed-price delivery order. It is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $4,255.27, is for the delivery of Telmisartan-HCTZ 80-25 mg tablets. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of July 29, 2024. AmerisourceBergen has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...